Skip to content

A single center, open label, randomized controlled trial to evaluate the perioperative outcomes of the lateral Jackknife position versus the lateral decubitus position during the uniportal video-assisted thoracoscopic lung cancer surgery

A single center, open label, randomized controlled trial to evaluate the perioperative outcomes of the lateral Jackknife position versus the lateral decubitus position during the uniportal video-assisted thoracoscopic lung cancer surgery - Thoracic Oncology Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074799
Enrollment
Unknown
Registered
2023-08-16
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

the lateral Jackknife position :the lateral Jackknife position
the lateral decubitus position:the lateral decubitus position

Sponsors

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age range from 18 to 75 years old; 2. ECOG physical condition score: 0-1 points; 3. Patients with multiple pulmonary nodules on chest thin slice CT should have = 3 nodules on the surgical side; 4. Radiologically diagnosed as resectable (cI-IIIA stage) lung cancer, or evaluated as resectable after neoadjuvant treatment, using a single hole thoracoscopy [through the lateral chest wall rib space, with a single incision of approximately 3-4cm in length and without the use of a rigid rib distractor] as the surgical approach; 5. According to the "Guidelines for the Diagnosis and Treatment of Primary Lung Cancer (2022 Edition)", the patient's surgical objective is radical resection; 6. The subjects can fully understand the clinical research requirements; 7. The subject or legal representative signs the informed consent form related to the clinical trial.

Exclusion criteria

Exclusion criteria: 1. Previous history of autoimmune diseases; 2. Previous history of vertebral body diseases and/or surgeries; 3. Previous rib and/or sternal diseases and/or surgical history; 4. Previous history of shoulder and/or hip joint diseases and/or surgeries; 5. Previous history of lung and thoracic surgery and procedures; 6. History of malignant tumors in the lungs or other organs; 7. Patients with severe other organ diseases who cannot tolerate surgery under general anesthesia.

Design outcomes

Primary

MeasureTime frame
Postoperative Pain Score;

Secondary

MeasureTime frame
The time of position;Operative time;Intraoperative blood loss;Conversion rate;Peak airway pressure;The widest diameter;

Countries

China

Contacts

Public ContactXiangyang Yu

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.

yuxy@chcamssz.ac.cn+86 173 1026 9673

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026